ATARA BIOTHERAPEUTICS, INC. Liabilities, Noncurrent
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Liabilities, Noncurrent of $13.00 million as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2019-02-26
- 2018-12-31: Liabilities, Noncurrent $13.00M.
- 2018-09-30: Liabilities, Noncurrent $12.89M.
- 2018-06-30: Liabilities, Noncurrent $12.97M.
- 2018-03-31: Liabilities, Noncurrent $12.88M.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2018-12-31 | $13.00M 10-K · filed 2019-02-26 |
| 2018-09-30 | $12.89M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $12.97M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $12.88M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $12.27M 10-K · filed 2019-02-26 |
| 2017-09-30 | $7.22M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $11.53M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $799.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $503.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $527.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $563.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $284.00K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $166.00K 10-K · filed 2017-03-09 |
| 2014-12-31 | $216.00K 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |